3.8 Article

Vendor effects on murine gut microbiota and its influence on lipopolysaccharide-induced lung inflammation and Gram-negative pneumonia

Journal

INTENSIVE CARE MEDICINE EXPERIMENTAL
Volume 8, Issue 1, Pages -

Publisher

SPRINGER
DOI: 10.1186/s40635-020-00336-w

Keywords

Intestinal microbiota; Vendor; Lipopolysaccharide; Klebsiella pneumoniae; Pulmonary Inflammation; Infection; Pneumonia; Sepsis

Funding

  1. Horizon2020 Marie Sklodowska-Curie International Training Network the European Sepsis Academy
  2. Netherlands Organization for Scientific Research (NWO, Vidi-grant)
  3. Netherlands Organization for Health Research development (ZonMw)

Ask authors/readers for more resources

Background The microbiome has emerged as an important player in the pathophysiology of a whole spectrum of diseases that affect the critically ill. We hypothesized that differences in microbiota composition across vendors can influence murine models of pulmonary lipopolysaccharide (LPS) inflammation and Gram-negative pneumonia. Methods A multi-vendor approach was used with genetically similar mice derived from three different vendors (Janvier, Envigo, Charles River). This model was employed to study the effect on the host response to a pulmonary LPS challenge (1 mu gKlebsiella pneumoniaeLPS, intranasal), as well as experimentalK. pneumoniaeinfection (ATCC43816,1 x 10(4)CFU, intranasal). Results Gut microbiota analysis revealed profound intervendor differences in bacterial composition as shown by beta diversity and at various taxonomic levels. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 release in lung and bronchoalveolar lavage fluid (BALF) were determined 6 and 24 h after intranasal treatment with LPS. No differences were found between the groups, with the exception for Envigo, showing a higher level of TNF alpha in lung and BALF at 6 h compared to Janvier and Charles River. In another set of experiments, mice from different vendors were subjected to a clinically relevant model of Gram-negative pneumonia (K. pneumoniae). At 12 and 36 h post-infection, no intervendor differences were found in bacterial dissemination, or TNF alpha and IL-6 levels in the lungs. In line, markers for organ failure did not differ between groups. Conclusions Although there was a marked variation in the gut microbiota composition of mice from different vendors, the hypothesized impact on our models of pulmonary inflammation and severe pneumonia was limited. This is of significance for experimental settings, showing that differences in gut microbiota do not have to lead to differences in outcome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available